Gastroesophageal Reflux Disease and the Role of Prokinetics Along with PPIS

Authors

  • Manish Kumar Arya Department of Medicine, MGM Medical College and LSK Hospital, Kishanganj, Bihar, India

DOI:

https://doi.org/10.37591/rrjom.v6i2.1524

Abstract

 

Gastroesophageal reflux disease (GERD) is often confused with functional dyspepsia as dyspepsia symptom commonly coexist with heartburn and some patients with functional dyspepsia respond to proton pump inhibitor (PPI) therapy. Up to 25–50% of patients with functional dyspepsia defined according to Rome III criteria can have abnormal esophageal acid exposure. Functional dyspepsia presents of one or more of the following symptoms: Postprandial fullness, early satiation, epigastric pain or burning, and no evidence of structural disease. Symptoms last for at least three months with the onset at least six months before diagnosis. Based on the prominent symptoms, it can be categorized into postprandial distress syndrome and epigastric pain syndrome.

 

Keywords: Gastroesophageal reflux, diaphragm, proton pump inhibitor, refractory patients

Cite this Article

Arya MK. Gastroesophageal Reflux Disease and the Role of Prokinetics Along with PPIS. Research and Reviews: Journal of Medicine. 2016; 6(2): 12–14p.

Downloads

Published

2019-05-01

Issue

Vol. 6 No. 2 (2016)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.